Hospital Universitario la Fe; Servicio de Hematologia
Valencia, Spain
Hospital in Valencia
Avinguda de Fernando Abril Martorell, 106, 46026 València, Valencia
About Hospital Universitario la Fe; Servicio de Hematologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
Institut de Recherches Internationales Servier
2
Clavis Pharma
1
Clinical Trials at Hospital Universitario la Fe; Servicio de Hematologia
During the past decade, Hospital Universitario la Fe; Servicio de Hematologia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)
2007-11-21
2016-05-20
Completed
86
Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)
2010-06-01
2013-06-01
Completed
381
A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia
2013-11-04
2018-10-08
Completed
979
A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment
2015-05-26
2017-03-31
Completed
221
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
2015-12-30
2020-04-24
Terminated
447
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors
2015-11-18
2020-12-01
Completed
113
A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
2016-07-22
2020-11-11
Completed
88
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A
2017-01-30
2022-06-29
Completed
48
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario la Fe; Servicio de Hematologia"
#1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator and "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hospital Universitario la Fe; Servicio de Hematologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitario la Fe; Servicio de Hematologia" are
"Hemophilia A" (5 trials), "Acute Myeloid Leukemia" (2 trials), "Acute Myeloid Leukaemia" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Hospital Universitario la Fe; Servicio de Hematologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario la Fe; Servicio de Hematologia
Most popular intervention types in "Hospital Universitario la Fe; Servicio de Hematologia" are "Drug" (12 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Emicizumab" (4 trials), "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials), "Bendamustine" (1 trials) and "Bypassing Agents" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario la Fe; Servicio de Hematologia
The vast majority of trials in "Hospital Universitario la Fe; Servicio de Hematologia" are
12 trials for "All" genders.
Clinical Trials Status at Hospital Universitario la Fe; Servicio de Hematologia
Currently, there are NaN active trials in "Hospital Universitario la Fe; Servicio de Hematologia".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Hospital Universitario la Fe; Servicio de Hematologia,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario la Fe; Servicio de Hematologia, 3 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Hospital Universitario la Fe; Servicio de Hematologia
Hospital Universitario la Fe; Servicio de Hematologia has several departments that took part in Clinical trials: "Unidad de Coagulopatias Congenitas Hospital Universitario la Fe" - 2 trials, "Hospital La Fe - Hematology" - 2 trials
Departments List
Name
City
Trials